← Back to Search

Compassion Cohort for Breast Cancer

N/A
Waitlist Available
Led By Claire Smith, MD
Research Sponsored by Dana-Farber Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Patient of any gender with unresectable locally advanced or metastatic breast cancer
* Eligible for in-home hospice services and referred by DFCI clinical team to in-home hospice \</= 1 week before enrollment
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 4 weeks
Awards & highlights

Summary

The aim of this research study is to better understand the in-home hospice experience for participants, caregivers, hospice nurses, and oncology providers by conducting telehealth check-ins between participants and caregivers and oncology care teams.

Who is the study for?
The COMPASSION Study is for individuals with breast cancer who are currently receiving in-home hospice care. It's designed to understand the experience of patients, caregivers, and healthcare providers by using telehealth check-ins.
What is being tested?
This study tests the effectiveness of telehealth visits as a way to support people with breast cancer and their caregivers during in-home hospice care, involving regular virtual interactions with oncology teams.
What are the potential side effects?
Since this trial involves non-medical interventions like telehealth visits, there are no direct medical side effects associated. However, participants may experience emotional or psychological impacts.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 4 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Proportion of Participant Intervention Completion

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Compassion CohortExperimental Treatment1 Intervention
25 participants will complete study procedures as follows: * Introduction to study and survey by brief, verbal consent via phone call. * At 4-6 weeks: survey completion via email or phone. * 4 weekly check-ins via Zoom or phone call with study team.
Group II: Usual Care CohortActive Control1 Intervention
25 participants will complete study procedures as follows: * Introduction to study and survey by brief, verbal consent via phone call. * At 4-6 weeks: survey completion via email or phone.

Find a Location

Who is running the clinical trial?

Dana-Farber Cancer InstituteLead Sponsor
1,098 Previous Clinical Trials
344,972 Total Patients Enrolled
144 Trials studying Breast Cancer
22,712 Patients Enrolled for Breast Cancer
Claire Smith, MDPrincipal InvestigatorDana-Farber Cancer Institute
~133 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top